Literature DB >> 269686

A cheap oral therapy for Paget's disease of bone.

R A Evans.   

Abstract

Nine patients with painful Paget's disease of bone were treated for 200 days with a drug combination designed to elevated plasma calcium, hence stimulating the production of endogenous calcitoning and suppressing that of parathyroid hormone. This combination was oral calcium, a thiazide diuretic, a low phosphorus diet and aluminium hydroxide. Eight of the nine patients experienced sustained pain relief after 20--70 days. The mean plasma alkaline phosphatase (expressed as a percentage of the pre-treatment level) commenced to fall after 30 days of treatment and at 120 days was 58% of the pre-treatment level; this fall was sustained at 200 days. There was a mean rise of 0-08 mmol/l in plasma calcium; there was no significant change in plasma inorganic phosphorus or plasma creatinine. In view of the extremely low cost of this drug combination and its lack of side-effects, it is suggested it be considered as a treatment for Paget's disease of bone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 269686     DOI: 10.1111/j.1445-5994.1977.tb03682.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  2 in total

1.  Paget's disease of bone: assessment and management.

Authors:  H K Ibbertson; T R Fraser; D J Scott; J C Cullen; J W Henley; E S Stephens; B Tait; D J Wattie
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

2.  Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.

Authors:  R A Evans; N M Somers; C R Dunstan; E Hills; M Evans
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.